A novel combination treatment targeting BCL-XL and MCL1 for KRAS/BRAF-mutated and BCL2L1-amplified colorectal cancers.
Molecular cancer therapeutics 2017 Jun .
Cho Sung-Yup, Han Jee Yun, Na Deukchae, Kang Wonyoung, Lee Ahra, Kim Jooyoung, Lee Jieun, Min Seoyeon, Kang Jinjoo, Chae Jeesoo, Kim Jong-Il, Park Hansoo, Lee Won-Suk, Lee Charl
Prostaglandin synthase 2/cyclooxygenase 2 (PTGS2/COX2) 8473T>C polymorphism associated with prognosis for patients with colorectal cancer treated with capecitabine and oxaliplatin.
Cancer chemotherapy and pharmacology 2009 Oct 64 (5): 953-60.
Kim Jong Gwang, Chae Yee Soo, Sohn Sang Kyun, Moon Joon Ho, Ryoo Hun Mo, Bae Sung Hwa, Kum Yoonseop, Jeon Seong Woo, Lim Kyoung-Hoon, Kang Byung-Mo, Park In-Ja, Choi Gyu Seog, Jun Soo-H